Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 11/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18486112 | 1.00 | AR (0.36) | AR | |
| SCHEMBL18485991 | 0.93 | AR (0.37) | AR | |
| SCHEMBL18486054 | 0.93 | AR (0.37) | AR | |
| SCHEMBL18486057 | 0.89 | AR (0.36) | AR | |
| SCHEMBL18486040 | 0.89 | AR (0.36) | AR | |
| SCHEMBL18486059 | 0.89 | AR (0.36) | AR | |
| SCHEMBL18486043 | 0.89 | AR (0.36) | AR | |
| SCHEMBL18486134 | 0.87 | KDM4E (0.42) | AR | |
| SCHEMBL18486021 | 0.87 | KDM4E (0.42) | AR | |
| SCHEMBL18486039 | 0.86 | AR (0.37) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180238899-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | HIROSAKI UNIVERSITY (JP) | 2018-08-23 | — | — | US | disclosed |
| US-10001487-B2 | Glucose derivative, and cell imaging method and imaging agent using said derivative | HIROSAKI UNIVERSITY (JP) | 2018-06-19 | — | — | US | disclosed |
| US-20170122955-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | HIROSAKI UNIVERSITY (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3130596-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | Hirosaki University (JP) | 2017-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170122955-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | SLC2A4, SLC2A1, UGGT1 | AR 4179/4885 |
| US-10001487-B2 | Glucose derivative, and cell imaging method and imaging agent using said derivative | SLC2A4, SLC2A1, G6PD | AR 3967/4885 |
| US-20180238899-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | SLC2A4, SLC2A1, UGGT1 | AR 4170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.